AngioDynamics to host conference call today at 11:30 am ET Increases Scale in Vascular Access and Peripheral Vascular Markets Expands Product Portfolio and Adds Innovative Technologies Strengthens Focus on Operational Excellence Expected to be Accretive in FY13 ALBANY, N.Y. and MARLBOROUGH, Mass.

Company Implements Voluntary Recall of Ablation Zone Estimator Software on NanoKnife ® Systems Installed in the U.S. Resumption of NeverTouch ® Procedure Kit Shipments Leads to Better Than Expected Demand ALBANY, N.Y. , Jan. 24, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a

ALBANY, N.Y. , Jan. 6, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 30th Annual J.P.

ALBANY, N.Y. , Jan. 5, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fiscal 2012 second quarter ended

ALBANY, N.Y. , Dec. 29, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 second quarter financial

'NanoKnife Low Energy Direct Current (LEDC) System in Subjects with Locally Advanced Unresectable Pancreatic Cancer' Led by Prof. Claudio Bassi at Univ. of Verona

ALBANY, N.Y. , Nov. 30, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the Canaccord Genuity Cardiovascular, Aesthetics &

ALBANY, N.Y. , Nov. 22, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the Piper Jaffray Healthcare Conference on Tuesday,

ALBANY, N.Y. , Nov. 8, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, appointed Matthew Kapusta , Senior Vice President of Business Development,

Results Meet Company Guidance; Management Reiterates Full Fiscal Year Guidance Authorizes Stock Repurchase Program ALBANY, N.Y. , Oct. 6, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery,

ALBANY, N.Y. , Oct. 3, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the U.S. District Court for the Northern District of New York has

Multi-Center, Clinical Trial Using Irreversible Electroporation for the Treatment of Early-Stage HCC (ONC-205) Includes 26 Patients From Five Sites

ALBANY, N.Y. , Sept. 29, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 first quarter financial

ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that Scott Solano , Senior Vice President and Chief Technology Officer, has resigned

ALBANY, N.Y. , Sept. 12, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, has appointed Alan Panzer , 50, as Senior Vice President and General Manager of

ALBANY, N.Y. , Sept. 6, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, will present at CL King's 9th Annual Best Ideas Conference on Tuesday, September 13, 2011 ,

ALBANY, N.Y. , Aug. 25, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, will present at the Stifel Nicolaus Healthcare Conference on Thursday, September 8, 2011 ,

ALBANY, N.Y. --(BUSINESS WIRE)-- The Board of Directors of AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, appointed Joseph M. DeVivo President and Chief Executive Officer,

Q4 Net Sales of $56.4 Million ; 2011 Net Sales of $216.0 Million Q4 NanoKnife ® System Sales Up 170% versus Year Ago Quarter ; International Sales Rise 28% versus Year Ago Quarter Two Non-Cash Charges Totaling $6.4 Million Recorded in Q4 Q4 EPS of $0.11 Prior to Charges and $0.03 Loss Per

ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2011 fourth quarter and full year financial